3.2. Alteration of Immune Cell Reprogramming in TME and Potentiation of Immunotherapy Response in NSCLC-Bearing Mice by a Combination of Anti-CD47 Ab and Anti-CTLA4 Ab. The gene discussed is CTLA4; the disease is non-small cell lung carcinoma.